Most Recent
Construction PRO
A challenge to the City of Sydney's refusal to approve a digital billboard on the heritage-listed Grace Bros building has fallen flat, with a judge saying the sign would “dominate the skyline” and affect key views from Broadway.
NAB super fund trustee NULIS Nominees had no power to continue charging members for $165 million in fees to pay adviser commission after conflicted remuneration was banned in 2016, an appeals court has heard.
Construction PRO
The Albanese government has issued seven tenders for its $93.6 billion project to build a high-speed rail between Newcastle and Sydney, which is expected to cut travel time by more than half.
ASIC has filed proceedings against Auto & General, alleging tens of thousands of Budget Direct customers lost discounts they were promised and were overcharged premiums for several years.
A judge has approved a $13.5 million settlement in a class action against the director of collapsed sandalwood producer Quintis, but has reduced deductions sought by the plaintiff's lawyers and funder, and denied a payout to the funder of a competing case.
A Federal Circuit Court judge who has been in the spotlight for his decisions has scolded a Perth law firm and barrister facing a sexual harassment case, after they sought to vacate the trial date due to counsel availability.
AMP super members are set to receive $60 million in a class action stemming from the banking royal commission, with the average payout being under $100, a judge has heard.
Coles has told a court that its decision to change its discount policies was unsurprising during a period of significant inflation, denying claims by the ACCC that its ‘Down Down’ promotions were misleading.
Construction PRO
Highrise fitout company Starline Interiors has persuaded a court to return a $1.5 million payment dispute to an adjudicator, whose earlier decision against the head contractor on a luxury Gold Coast tower was declared void.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.